Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (181-190 of 549) with videos related to

Pageof 55
Sort By:
The Oncologist|May 2, 2008
A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimensIsabelle Ray-Coquard, Axel Le Cesne, Jeremy S Whelan, et al.
Bulletin Du Cancer|June 17, 2006
[Prognostic factors for febrile neutropenia]Isabelle Ray-Coquard, Christophe Borg, Thomas Bachelot, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancersNicholas Simon Reed, Patricia Pautier, Elizabeth Åvall-Lundqvist, et al.
JCO Precision Oncology|August 24, 2022
Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene LossXiaolan Feng, Haocheng Li, Joanna Fourquet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2026
Deep learning-based prediction of homologous recombination deficiency from histopathological whole-slide images in ovarian cancerJean-Sébastien Frenel, Pierre-Etienne Heudel, Emmanuelle Guinaudeau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 20, 2013
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trialBéatrice Weber, Rémy Largillier, Isabelle Ray-Coquard, et al.
Clinical Genitourinary Cancer|October 10, 2009
Drug management of prostate cancer: prevalence and consequences of renal insufficiencyVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer networkIsabelle Ray-Coquard, Thierry Philip, Guy de Laroche, et al.
Lung|October 23, 2008
Lung cancer and renal insufficiency: prevalence and anticancer drug issuesVincent Launay-Vacher, Reza Etessami, Nicolas Janus, et al.
Virchows Archiv : an International Journal of Pathology|April 25, 2023
CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotypeAlexis Trecourt, Nicolas Macagno, Carine Ngo, et al.
Pageof 55

Showing results (181-190 of 549) with videos related to

Sort By:
Pageof 55
The Oncologist|May 2, 2008
A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimensIsabelle Ray-Coquard, Axel Le Cesne, Jeremy S Whelan, et al.
Bulletin Du Cancer|June 17, 2006
[Prognostic factors for febrile neutropenia]Isabelle Ray-Coquard, Christophe Borg, Thomas Bachelot, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancersNicholas Simon Reed, Patricia Pautier, Elizabeth Åvall-Lundqvist, et al.
JCO Precision Oncology|August 24, 2022
Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene LossXiaolan Feng, Haocheng Li, Joanna Fourquet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2026
Deep learning-based prediction of homologous recombination deficiency from histopathological whole-slide images in ovarian cancerJean-Sébastien Frenel, Pierre-Etienne Heudel, Emmanuelle Guinaudeau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 20, 2013
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trialBéatrice Weber, Rémy Largillier, Isabelle Ray-Coquard, et al.
Clinical Genitourinary Cancer|October 10, 2009
Drug management of prostate cancer: prevalence and consequences of renal insufficiencyVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer networkIsabelle Ray-Coquard, Thierry Philip, Guy de Laroche, et al.
Lung|October 23, 2008
Lung cancer and renal insufficiency: prevalence and anticancer drug issuesVincent Launay-Vacher, Reza Etessami, Nicolas Janus, et al.
Virchows Archiv : an International Journal of Pathology|April 25, 2023
CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotypeAlexis Trecourt, Nicolas Macagno, Carine Ngo, et al.
Pageof 55